retatrutide approval 2025 Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide is the most significant

GLP-1 drops have broadened the options for people seeking out medications for weight loss, and are especially appealing for those who want a needle-free alternative

In one of the largest real-world studies to date examining obesity treatment use and long-term weight changes after GLP-1 discontinuation, researchers at Cleveland Clinic found that many patients successfully stabilized their weight after one year through alternative treatments and therapeutic lifestyle interventions

[4] Jastreboff, A

Some GLP-1 drugs appear more likely to cause gastrointestinal side effects than others

The realistic UK timeline Wegovy and Mounjaro give a useful indication of how long the regulatory process typically takes

Reference: [1]Huang, KP., Acosta, A.A., Ghidewon, M.Y